PRA Health Sciences anuncia el nombramiento de un nuevo consejero
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) ha anunciado hoy el nombramiento de Glen Stettin, doctor en medicina, como consejero del...
PRA Health Sciences anuncia nomeação de novo diretor
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, Carolina do Norte, Sept. 16, 2020 (GLOBE NEWSWIRE) -- A PRA Health Sciences, Inc. (NASDAQ:PRAH) anunciou hoje a nomeação do Doutor Glen Stettin para o Conselho de Administração da Empresa,...
PRA Health Sciences mengumumkan Pelantikan Pengarah Baharu
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) hari mengumumkan pelantikan Glen Stettin, M.D. kepada Lembaga Pengarah Syarikat, berkuat kuasa pada 14...
PRA Health Sciences annonce la nomination d'un nouveau directeur
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 16 sept. 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ : PRAH) a annoncé aujourd'hui la nomination de Glen Stettin, M.D., au conseil d'administration de la...
PRA Health Sciences宣布任命新董事
September 16, 2020 15:31 ET
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利, Sept. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc.（NASDAQ:PRAH）今天宣布任命Glen Stettin为公司董事，任命自2020年9月14日起生效。 ...
PRA Health Sciences Announces Appointment of New Director
September 15, 2020 16:02 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., Sept. 15, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) today announced the appointment of Glen Stettin, M.D. to the Board of Directors of the Company, effective...
PRA Health Sciences, Inc. Reports Second Quarter 2020 Results and Provides Third Quarter and Full Year 2020 Guidance
August 06, 2020 16:01 ET
|
PRA Health Sciences, Inc.
Net new business of $701.6 million; Net book-to-bill of 1.35 excluding reimbursement revenueNet new business of $1,083.3 million; Net book-to-bill of 1.62 including reimbursement revenue$729.9 million...
PRA Health Sciences to Report Second Quarter 2020 Earnings
July 02, 2020 13:20 ET
|
PRA Health Sciences, Inc.
RALEIGH, N.C., July 02, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ: PRAH) will release its second quarter 2020 results after the market closes on Thursday, August 6, 2020. The...
PRA 헬스사이언스, RACE 법 발효 앞두고 소아암 연구 역량 강화
June 18, 2020 16:54 ET
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, June 19, 2020 (GLOBE NEWSWIRE) -- 2007년부터 2017년까지 미국 FDA(식품의약국)가 승인한 성인용 신약 항암제는 총 78종이다1. 그러나 이 가운데 소아암 환자에 대한 효능이 연구된 약은 단 하나도 없다. 오는 8월 18일 RACE(어린이 신약 및 형평 증진 연구) 법이 발효되면 이 같은...
PRA Health Sciences ist bereit, die Anforderungen des RACE Act für die pädiatrische Onkologie zu erfüllen
June 18, 2020 16:54 ET
|
PRA Health Sciences, Inc.
RALEIGH, North Carolina, USA, June 18, 2020 (GLOBE NEWSWIRE) -- Zwischen 2007 und 2017 wurden 78 neue Krebsmittel für Erwachsene von der US-amerikanischen Food and Drug Administration...